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A 14-year old Micronesian female with no significant past medical
history presented to the emergenc department with tonic—dome
seizures. Earlier in the evening, the patient svent to the mos ies with
her family and vs as in her usual state of health. The patient had a
history of dental caries and had a toothache that evening. When
getting ready for bed. she received permission from her mother to
take another Limi Ix member’s medication to self—treat the tooth
pain. Within an hour of taking the medication, the patient’s mother
heard aloudcry from the patient’s roni. Atthat time, the patient was
found to behaving a generalized tonic-clonic seizure. An ambulance
was called, and when the paramedics arrived, she was unresponsive
and still actively seizing. She was given diazepam 3.5 mg intrave
nously without effect. She was given another 3.5 mg of diazepam
and the seizure resolved. The total time of the seizure was approxi—
matelv thirty minutes. The patient was transported to the emergency
department, remained unresponsive and began seizing again upon
her arrival.
The patient had no significant past medical history except dental
caries. She was born by normal spontaneous vaginal delivery in the
Marshall Islands. Her prenatal and postnatal courses were unre
markable. She had no previous hospitalizations, no surgeries, no
allergies and was on no routine medications. Her immunizations
were up to date. She had no recent travel, no exposure to toxins or
pets. did not smoke cigarettes. drink alcohol or take illicit drugs. and
had no significant family medical history. She was one of six
children, ages ranging from 2to 22 xears. Her parents weredisorced.
and the children lived with their mother. Her family stated that
escept for the toothache, she was perfectly well earl icr that evening
without anx complaints of trauma. headache, neck stiffness, photo
phobia, fever, rash or other problems. The medication she had taken
for her tooth pain belonged to a family member.
On physical exam, the patient was initially unresponsive and
having generalized tonic-clonic seizures. Her vital signs included:
heart rate 155 heats per minute: blood pressure 133/61: temperature
00.2 tympanic: oxygen saturation I 00% while receiving assisted
respirations and I 00% oxgcn. There vs crc no obvious rashes or
signs of trauma. Her pupils vs crc 4 mm and equal and reactive to
light. Her lungs were clear and her cardiac exam ‘.va normal except
for tachycardia. Her abdomen was soft, bowel sounds were present.
tIer extremities were normal. When the seizures had stopped. she
remained unresponsive and had nonpurposeful movements of all
extremities,
Laboratory studies obtained in the emergency department re
sealed: A white blood count of 26.7 x 1 0-JL with 68% neutrophils
and 32L lx mphocvtes: hemoglobin l 2.5 g/dL and hematocrit 36.7
platelets 322.00t). Chenutnes included: sodium 1 39 miuol/L
I 36-145): potassium 3.0 mmol/l. 3.3-5.1 : chloride 103 mmol!L
96—lO$i: bicarbonate $ minol;L 21—3 H: anion gap 28 (4—16: BL\
in,idL 6 lOi ( i t) 9 ni. dl it) 4 H Juvosv o2 iiLJdL ‘O
11W: calcium 9.1 mg/dI. 8.4—10.2): phosphorus 5.9 mg/dL )2.6—
4,5>, Liver function tests were within normal limits. An arterial
blood gas on 100% oxygen showed pH 7.19, pCO2 38. p02 504.
bicarbonate IS. base excess -l2 A urine toxicology screen was
negative for illegal drugs A urine pregnancx test was also negative.
Blood salicylate and acetaminophen levels were negative. A CT
scan of the head did not show any bleeding or masses.
The medication that the patient took for her toothache svas brought
to the emergency department by the paramedics. It was a regular
pharmacy prescription bottle labeled “amoxicillin”. The contents of
the bottle were inspected and two different types of pills were noted.
The first tpe was identified as amoxicillin. the other ss as isoniazicl.
The patient continued to seize. She vs as given phosphenvtoin and
phenobarhitol to control her seizures, and she was intubated At this
point. isoniazid toxicitx was suspected. so the patient ss as given 5
grams of psridoxine IV and activated charcoal. An isoniazid level
was obtained and later found to be 54.4 mcg/ml (toxic level is greater
than 10 meg/mI). An EEG showed a diffuse encephalopathic pro
cess with high amplitude delta wave and no seizure discharges. The
patient remained unresponsive and intuhated in the pediatric inten
sive care unit for ten days. On her tenth hospital dax . she became
arousable and fairE quickly became responsive. She ultimatelx
fully recovered and was discharged home.
Discussion
Isoniazid (INH) was introduced in 1952; it is the lix drazide of
isonicotinic acid. It is used for tuberculosis (TB) either as preventa
tive therapy or for active disease in combination with other medica
tions, The incidence of isoniazid toxicity in the pediatric population
is unknown; however. toxic events involving this medication have
increased as this medication is used with increasing frequency. With
the resurgence of tuberculosis in HIV-inf’ected patients and recent
immigrants from areas with endemic TB. INH usage has increased.
The State of Hawaii has a high per-capita rate of TB and people
immigrating from the Pacific Islands and Asia. where the prevalence
otT B is high. have contributed to the high rate here. Consequently.
INH use in Hawaii has also increased as therapy for active disease
or prophylaxis.
In children, the usual dose of INH is 10-15 mg/kg in contrast with
doses of 5 mg/kg in adults. Neurotoxicity and seizures can occur
with ingestion of 40 mg/kg or less. INH is 95% hioavailahle and
effects after a toxic dose are usuallx seen ss ithin 30 minutes to 2
hours of ingestionH Therapeutic doses in children result in peak
blood levels of 6—20 mg/mI. Toxic levels are greater than 10 mg/mI.
or 3.2 mg/mI tss o hours after ingestion. 0.2 mg/mI 6 hours after
ingestion. INH is metabolized b acetlanon and excreted chiefl
in the urine. The half-life depends on the acetylation status of the
patient which is a genetically determined factor. The half-life in
“fast” acetylators is approximately 90 minutes or less, and 180
minutes in “slow” acetylators.’ It is estimated that 60% of Cauca
sians and African-Americans are slow acetylators and 10% of
Asian—American and Alaskan natives are slow acetvlators:
latrocenic overdose of l\ H sshile takinc the medic anon as di
rected
‘ rare. One case described took place in a patient thought to
be a sloss acetvlator: vs ith the medication half—life doubled, it was
hxpothesi/ed that toxic levels were achieved while on therapeutic
doses.
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Most acute toxic events from INH come from either suicide attempt
or accidental ineestion .as with our patient. Another case in Hawaii
involved a teenage girl who ingested a large quantity of l\H in a
suicidal gesture after a tight with her hoyfriend she suffered a
seizure and was brought to the hospital by ambulance. One case-
series from Los Angeles involved three siblings and a possible
accidental overdose: a four-year old child was prescribed INH for a
positive PPI) and his two ounger siblingsiges 2 1/2 and 1 1/2
years, vere brought to the medical tiicilitv with generalized convul
sions. Another pediatric overdose occutTed when an intant was
prescribed 300 mg INH daily rather than 30 mg daily* One author
(Byron Aoki) saw long term complications in children with INH
induced seizures in the 1970’s who were not treated with pyridoxine.
They developed permanent neurologic damage in cognition and
behavior.
The classic clinical presentation of acute INH toxicity includes
the triad of refractory seizures, coma and metabolic acidosis. Other
features consist of slurred speech. ataxia. hvpotension. feser. pe
ripheral neuritis, nausea and vomiting. hypokalemia, leukocvtosis.
hyperglycemia with ketonuria and glycosuria.5 It is important that
the anion gap acidosis coupled with the hyperglycemia does not get
mistaken for diabetic ketoacidosis.3Our patient had many of these
features including refractory seizures, coma, wide anion gap meta
bolic acidois . leukocytosis. hvpokalemia and hyperglycemia.
The mechansim of seizures inlNH toxicity is thought to he due to
a depletion of the inhibitory neurotransmitter g-aminohutvric acid
(GABA):’ Decreased levels ofGABA can result in CNS excitability
and seizures. The synthetic pathway for GABA involves glutamic
acid decarhoxylase. Pyridoxine (vitamin B6) is activated to pyri
doxal-5-phosphate which is a cofactor for glutamic acid decarboxy
lase. INH. in overdose, binds free pvridoxal-5-phosphate. which
acutely lowers this: cofactor necessary for GABA synthesis, which
results in a seizure.7
The treatment of INH overdose includes the management of life-
threatening symptoms, administration of pvridoxine and supportive
care. The initial management includes airway control, maintenance
of respirations, and ensuring adequate circulation: this may require
endotracheal intubation. intravenous access and intravenous fluids.
To stop seizures in children, diazepam 0.1 -0.2 mg/kg or lorazepam
0.05-0.1 mg/kg can he given and repeated as needed. Diazepam is
thought to be more effective than other anticons ulsants in treating
[NI-I-induced seizures, perhaps acting with a s nergistic effect with
pridoxine. Pvridoxine should he given intra enouslv as soon as
possible. The pridoxine dose should he the same dose of INI-1 that
was taken (one gram of pyridoxine for every one gram of INH
ingested); if the amount INH ingested is not known, 5 grains of
pyridoxine IV over 5-10 minutes should he sufficient in most cases.7
If ingestion has occurred within an hour, gastric lavage can he
performed followed hc 15—30 grams 1-2 g/kg of charcoal with I -
1.5 grams/ke of sorhitol up to 50 erams as a slurry forchildren. The
charcoal dose without the sorhitol c an be repeated. I fthese mea’ tires
do not control the seizures. heniodialvsjs ma be necessary.
Isoniazid is the fourth leading cause of drug-induced seizures
accounting for approximately 5% of all seizures associated with
overdose. This is likely to increase following the rise in TB in our
community, In our patient, examination of the medication taken
indicated this was likely an INH on erdose. \Vhen the preceding
history is not clear, the possibility of INN toxicity must he strongl
considered in an case of refractory seizures with metabolic acido—
sis. Treatment with pyridoxine must he considered as it can dramati
cally alter the patient’s outcome. Finally, emergency departments
must he sure that enough pyridoxine is available for treatment.
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